Abstract:Alzheimer's disease (AD) is the leading cause of mortality, disability, and long‐term care burden in the United States, with women comprising the majority of AD diagnoses. While AD‐related dementia is associated with tau and amyloid beta accumulation, concurrent derangements in cerebral blood flow have been observed alongside these proteinopathies in humans and rodent models. The homeostatic production of nitric oxide synthases (NOS) becomes uncoupled in AD which leads to decreased NO‐mediated vasodilation and oxidative stress via the production of peroxynitrite (ONOO−∙) superoxide species. Here, we investigate the role of the novel protein arginine methyltransferase 4 (PRMT4) enzyme function and its downstream product asymmetric dimethyl arginine (ADMA) as it relates to NOS dysregulation and cerebral blood flow in AD. ADMA (type‐1 PRMT product) has been shown to bind NOS as a noncanonic ligand causing enzymatic dysfunction. Our results from RT‐qPCR and protein analyses suggest that aged (9−12 months) female mice bearing tau‐ and amyloid beta‐producing transgenic mutations (3xTg‐AD) express higher levels of PRMT4 in the hippocampus when compared to age‐ and sex‐matched C57BL6/J mice. In addition, we performed studies to quantify the expression and activity of different NOS isoforms. Furthermore, laser speckle contrast imaging analysis was indicative that 3xTg‐AD mice have dysfunctional NOS activity, resulting in reduced production of NO metabolites, enhanced production of free‐radical ONOO−, and decreased cerebral blood flow. Notably, the aforementioned phenomena can be reversed via pharmacologic PRMT4 inhibition. Together, these findings implicate the potential importance of PRMT4 signaling in the pathogenesis of Alzheimer's‐related cerebrovascular derangement.

Protein Arginine Methyltransferases in Cardiovascular and Neuronal Function

Critical Roles of Protein Arginine Methylation in the Central Nervous System

Protein arginine methylation of non-histone proteins and its role in diseases.

The regulation, functions and clinical relevance of arginine methylation

Protein arginine methylation: from enigmatic functions to therapeutic targeting

The role of protein arginine N-methyltransferases in inflammation

The Role Of Protein Arginine Methyltransferases In Kidney Diseases

Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1

Independent transcriptomic and proteomic regulation by type I and II protein arginine methyltransferases

Chemical probes and methods for the study of protein arginine methylation

Protein arginine methyltransferases in renal development, injury, repair, and fibrosis.

Theoretical insights into catalytic mechanism of protein arginine methyltransferase 1

Protein arginine methyltransferase 8 modulates mitochondrial bioenergetics and neuroinflammation after hypoxic stress

Protein Arginine Methyltransferases (PRMTs): Orchestrators of Cancer Pathogenesis, Immunotherapy Dynamics, and Drug Resistance

Small Molecule Inhibitors of Protein Arginine Methyltransferases

The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease

Overview of PRMT1 modulators: Inhibitors and degraders

Protein Arginine Methylation in Viral Infection and Antiviral Immunity

Substrate Specificity, Processivity, and Kinetic Mechanism of Protein Arginine Methyltransferase 5

The Structure and Functions of PRMT5 in Human Diseases